Save the date:
Monday, May 3
1:30 - 2:30pm EDT
Everyone is welcome to attend the virtual 2021 Women in Eye and Vision Research (WEAVR) Event and hear from our keynote speaker, Katherine High, MD. We are pleased to announce the event will be open to all ARVO 2021 registrants at no additional fee!
Keynote: Merging Discovery and Entrepreneurship in the Field of Gene Therapy
Katherine High, MD
Professor Emerita, Perelman School of Medicine of the University of Pennsylvania
President, Therapeutics, Asklepios BioPharmaceutical
Co-founder and former president and head of R&D, Spark Therapeutics
Katherine A. High, MD, is president of AskBio, Therapeutics where she is responsible for driving the strategic direction and execution of the company’s preclinical and clinical programs. She is also a member of the AskBio Board of Directors.
Prior to this, High co-founded Spark Therapeutics, Inc., where she served as president and head of Research and Development (2014 - 2020), and was a member of the Board of Directors from 2014 - 2019. At Spark, High gained approval of the first gene therapy for a genetic disease in the U.S., and the first AAV product. She also led the Spark development programs for hemophilia B and hemophilia A, both of which earned FDA Breakthrough Therapy Designation.
All proceeds from the WEAVR Event support women in the visual sciences. Funds raised support travel grants and Developing Country Eye Researcher Travel Fellowships for female scientists to attend the ARVO Annual Meeting. Proceeds also underwrite the Women's Leadership Development Program.
Sponsorships are on sale now! Learn more